ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Sangamo Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Sangamo Therapeutics, INC. (Sangamo Therapeutics INC. 401(k) Profit Sharing Plan And Trust · EIN 68-0359556 · PN 001): $62.51M net assets, 181 active participants, and $9.14 per $10,000 (9.14 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSangamo Therapeutics, INC.
Filing IdentifierSangamo Therapeutics INC. 401(k) Profit Sharing Plan And Trust · EIN 68-0359556 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$62.51M
Active Participants181
Direct Admin Fee Rate$9.14 per $10,000 (9.14 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderOnedigital Investment Advisors LLC
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI